Atlas Trials

A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

Clinical trial NCT06593938 · COMPLETED

Trial details

NCT number
NCT06593938
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria
Start date
2024-10-25
Primary completion
2025-07-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.